Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

FRAXINUS EXCELSIOR DIN 02234493

Status: Cancelled Post Market
Holder: DOLISOS CANADA INC.
Molecule: FRAXINUS EXCELSIOR

Health Canada record

Active ingredient(s)FRAXINUS EXCELSIOR 1 X
Dosage formGlobules; Liquid; Granules
RouteOral
ScheduleHOMEOPATHIC
ClassHuman
ATC
Original market date05-Jan-1998
Current status date20-Apr-2006
SourceHealth Canada DPD

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing FRAXINUS EXCELSIOR

DINProductCompanyFormStrengthStatus
02233988FRAXINUS EXCELSIORHOMEOCAN INC.Globules; Drops; GranulesFRAXINUS EXCELSIOR 1 XCancelled Post Market
02233145FRAXINUS EXCELSIORSEROYAL INTERNATIONAL INC.Pellet; Granules; Tablet; Drops; Globules; LiquidFRAXINUS EXCELSIOR 1 XCancelled Post Market
01917994FRAXINUS EXCELSIOR GRANULE 1DH-30CHHOMEOCAN INC.TabletFRAXINUS EXCELSIOR 1 DHCancelled Post Market
Request a quote for FRAXINUS EXCELSIOR

How to read a Canadian DIN record